| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0007 |